Volition is developing simple, easy to use blood-based Nu.Q™ immunoassay tests to accurately diagnose a range of cancers. Our first test, the Nu.Q™ colorectal cancer screening triage test, is designed to identify patients who have received a false positive result on their FIT test and ensures that fewer patients are referred for unnecessary colonoscopies. Diagnostic tests for people with symptoms for colorectal cancer as well as a screening test for average risk populations are in development.
Included in the Export Interest Directory? No
Business Needs: Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements
Products to be exported: Nu.Q™ Research Use Only Immuno Assay Kits
Countries of Interest: 1. All Countries listed below